FIBRINOGEN HUMAN

FIBRINOGEN HUMAN was reported 233 times

FIBRINOGEN HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL DYSFIBRINOGENAEMIA 2 0.1667
1 HEPATIC ARTERY HAEMORRHAGE 1 0.1429
2 HAEMORRHAGE FOETAL 3 0.0566
3 INHIBITING ANTIBODIES POSITIVE 3 0.0526
4 HEPATITIS B E ANTIBODY POSITIVE 1 0.0455
5 FOETAL-MATERNAL HAEMORRHAGE 2 0.0417
6 TRACHEOSTOMY TUBE REMOVAL 1 0.0270
7 PLEURAL INFECTION BACTERIAL 1 0.0256
8 PORTAL VEIN CAVERNOUS TRANSFORMATION 1 0.0244
9 FOETAL ANAEMIA 3 0.0229
10 ANTI FACTOR X ACTIVITY INCREASED 1 0.0185
11 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
12 BRONCHIAL INJURY 1 0.0172
13 VISCERAL VENOUS THROMBOSIS 1 0.0167
14 PORTOSPLENOMESENTERIC VENOUS THROMBOSIS 1 0.0164
15 CITROBACTER TEST POSITIVE 1 0.0152
16 ISCHAEMIC ENTERITIS 1 0.0103
17 SHUNT THROMBOSIS 1 0.0101
18 DEFICIENCY OF BILE SECRETION 1 0.0100
19 POSTOPERATIVE RESPIRATORY FAILURE 1 0.0096
20 MYOCARDIAL HAEMORRHAGE 1 0.0091
21 BILIARY ANASTOMOSIS COMPLICATION 1 0.0083
22 GRAFT THROMBOSIS 2 0.0076
23 HEPATIC ARTERY THROMBOSIS 2 0.0068
24 OVARIAN VEIN THROMBOSIS 1 0.0066
25 ALLERGIC TRANSFUSION REACTION 1 0.0066
26 BILIARY FISTULA 1 0.0065
27 SUBGALEAL HAEMATOMA 1 0.0060
28 POST PROCEDURAL STROKE 1 0.0054
29 ACINETOBACTER TEST POSITIVE 1 0.0052
30 THROMBOSIS MESENTERIC VESSEL 1 0.0044
31 RENAL GRAFT INFECTION 1 0.0043
32 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 1 0.0041
33 BUDD-CHIARI SYNDROME 1 0.0040
34 UTERINE INFECTION 2 0.0038
35 INFUSION SITE THROMBOSIS 1 0.0037
36 GASTROINTESTINAL ISCHAEMIA 1 0.0036
37 COR PULMONALE ACUTE 1 0.0036
38 SHUNT MALFUNCTION 1 0.0035
39 GRAFT DYSFUNCTION 1 0.0035
40 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
41 BRONCHIAL HAEMORRHAGE 1 0.0032
42 HEPATIC VEIN THROMBOSIS 1 0.0032
43 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
44 CHOLURIA 1 0.0029
45 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
46 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
47 MYOCARDIAL OEDEMA 1 0.0025
48 TRANSPLANTATION COMPLICATION 1 0.0024
49 HEPATIC HAEMATOMA 1 0.0021
50 HYPOPROTEINAEMIA 4 0.0021
51 LACTATION DISORDER 1 0.0021
52 SHUNT OCCLUSION 1 0.0020
53 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
54 BRONCHOSTENOSIS 1 0.0018
55 JUGULAR VEIN DISTENSION 1 0.0018
56 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
57 DOSE CALCULATION ERROR 1 0.0017
58 GRAFT COMPLICATION 1 0.0017
59 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
60 MECHANICAL VENTILATION 3 0.0016
61 ENTEROCOCCUS TEST POSITIVE 1 0.0015
62 ALLERGIC OEDEMA 1 0.0015
63 POST PROCEDURAL SEPSIS 1 0.0015
64 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
65 SURGICAL PROCEDURE REPEATED 1 0.0015
66 CAPILLARY LEAK SYNDROME 3 0.0014
67 HAEMORRHAGE IN PREGNANCY 2 0.0014
68 SOFT TISSUE INJURY 1 0.0013
69 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
70 MAMMOPLASTY 1 0.0013
71 TONSIL CANCER 1 0.0012
72 ENTEROCOCCAL SEPSIS 1 0.0012
73 POUCHITIS 1 0.0012
74 ABDOMINAL SEPSIS 1 0.0011
75 LIVER TRANSPLANT REJECTION 2 0.0011
76 INTESTINAL INFARCTION 1 0.0011
77 BONE CONTUSION 1 0.0011
78 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
79 RED BLOOD CELLS URINE POSITIVE 1 0.0010
80 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
81 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
82 SUBCUTANEOUS EMPHYSEMA 1 0.0010
83 HYPOFIBRINOGENAEMIA 1 0.0010
84 BRAIN DEATH 3 0.0010
85 HYPOPERFUSION 1 0.0010
86 ACINETOBACTER INFECTION 1 0.0009
87 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
88 HYPOCHLORAEMIA 1 0.0009
89 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
90 CEREBRAL ARTERY EMBOLISM 1 0.0008
91 MONOCYTE COUNT DECREASED 1 0.0008
92 COMPARTMENT SYNDROME 2 0.0008
93 POSTPARTUM HAEMORRHAGE 1 0.0007
94 HYPERURICAEMIA 3 0.0007
95 PERITONEAL HAEMORRHAGE 1 0.0007
96 ECHOCARDIOGRAM ABNORMAL 1 0.0007
97 PERIPHERAL ARTERY OCCLUSION 1 0.0007
98 PELVIC VENOUS THROMBOSIS 1 0.0007
99 PULMONARY SEPSIS 1 0.0007
100 HEPATITIS E 1 0.0006
101 PHARYNGEAL PARAESTHESIA 1 0.0006
102 ACUTE LEUKAEMIA 1 0.0006
103 HEPATITIS ACUTE 4 0.0006
104 THROMBOSIS IN DEVICE 2 0.0006
105 ENTEROBACTER INFECTION 1 0.0006
106 SPLENIC INFARCTION 1 0.0006
107 AORTIC VALVE STENOSIS 1 0.0006
108 TRANSPLANT DYSFUNCTION 1 0.0006
109 PNEUMOMEDIASTINUM 1 0.0006
110 VENOUS OCCLUSION 1 0.0005
111 SOFT TISSUE INFECTION 1 0.0005
112 DENTAL CARE 1 0.0005
113 SMALL INTESTINAL PERFORATION 1 0.0005
114 TRAUMATIC HAEMORRHAGE 1 0.0005
115 HYPOALBUMINAEMIA 4 0.0005
116 PROCEDURAL HAEMORRHAGE 2 0.0005
117 FOETAL GROWTH RESTRICTION 3 0.0005
118 SHOCK HAEMORRHAGIC 4 0.0005
119 PERIPHERAL ISCHAEMIA 2 0.0005
120 DILATATION VENTRICULAR 1 0.0005
121 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
122 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
123 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
124 TEMPERATURE REGULATION DISORDER 1 0.0004
125 BLOOD LOSS ANAEMIA 1 0.0004
126 FLAT AFFECT 1 0.0004
127 CARDIAC TAMPONADE 2 0.0004
128 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
129 HYPERNATRAEMIA 2 0.0004
130 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
131 LYMPHOCYTE COUNT DECREASED 7 0.0004
132 ABDOMINAL INFECTION 1 0.0004
133 POOR VENOUS ACCESS 4 0.0004
134 SUBDURAL HAEMORRHAGE 1 0.0004
135 INTRACRANIAL PRESSURE INCREASED 2 0.0004
136 PARAPLEGIA 1 0.0003
137 COMA SCALE ABNORMAL 1 0.0003
138 HAEMOTHORAX 1 0.0003
139 URINE OUTPUT DECREASED 3 0.0003
140 GASTROINTESTINAL NECROSIS 1 0.0003
141 RESPIRATORY RATE INCREASED 3 0.0003
142 BRAIN HERNIATION 1 0.0003
143 HEPATITIS B 2 0.0003
144 CENTRAL VENOUS CATHETERISATION 1 0.0003
145 INTRACARDIAC THROMBUS 1 0.0003
146 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
147 BODY TEMPERATURE DECREASED 3 0.0003
148 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
149 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
150 CEREBRAL HAEMATOMA 1 0.0003
151 WOUND COMPLICATION 1 0.0003
152 THROMBOPHLEBITIS 1 0.0003
153 LOGORRHOEA 1 0.0003
154 HAEMORRHAGIC DIATHESIS 1 0.0003
155 MYELODYSPLASTIC SYNDROME 4 0.0003
156 THROMBOCYTOSIS 1 0.0003
157 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
158 HAEMODYNAMIC INSTABILITY 2 0.0003
159 POST PROCEDURAL HAEMORRHAGE 3 0.0003
160 VENOUS THROMBOSIS 1 0.0003
161 CYTOKINE RELEASE SYNDROME 5 0.0002
162 ESCHERICHIA INFECTION 2 0.0002
163 ANAPHYLACTOID REACTION 1 0.0002
164 COAGULOPATHY 4 0.0002
165 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
166 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
167 UTERINE HAEMORRHAGE 1 0.0002
168 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
169 ILEUS PARALYTIC 1 0.0002
170 HAEMARTHROSIS 2 0.0002
171 EYE OPERATION 1 0.0002
172 SKIN ABRASION 1 0.0002
173 HYPOCALCAEMIA 4 0.0002
174 PRODUCT PACKAGING ISSUE 2 0.0002
175 PRE-ECLAMPSIA 1 0.0002
176 SUBDURAL HAEMATOMA 3 0.0002
177 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
178 HYPOVOLAEMIC SHOCK 1 0.0002
179 CEREBRAL INFARCTION 5 0.0002
180 HYPERVOLAEMIA 1 0.0002
181 ANEURYSM 1 0.0002
182 PROTEIN URINE PRESENT 1 0.0002
183 PARTIAL SEIZURES 1 0.0002
184 BLOOD LACTIC ACID INCREASED 1 0.0002
185 NO ADVERSE EVENT 34 0.0002
186 NORMAL NEWBORN 1 0.0002
187 JAW DISORDER 1 0.0002
188 ACUTE PULMONARY OEDEMA 1 0.0002
189 PREMATURE LABOUR 1 0.0002
190 LARYNGEAL OEDEMA 1 0.0002
191 CHOLANGITIS 1 0.0002
192 SWELLING OF EYELID 1 0.0002
193 MULTIPLE INJURIES 1 0.0002
194 ANAPHYLACTIC SHOCK 4 0.0002
195 PRODUCT PREPARATION ISSUE 1 0.0002
196 ASPERGILLUS INFECTION 1 0.0002
197 DYSGRAPHIA 1 0.0002
198 APPETITE DISORDER 1 0.0002
199 CARDIAC FAILURE ACUTE 1 0.0001
200 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
201 DEFAECATION URGENCY 1 0.0001
202 RIGHT VENTRICULAR FAILURE 1 0.0001
203 HAND FRACTURE 1 0.0001
204 ASCITES 4 0.0001
205 HYPOPHOSPHATAEMIA 1 0.0001
206 PREMATURE BABY 4 0.0001
207 PLEURAL EFFUSION 8 0.0001
208 ACIDOSIS 1 0.0001
209 INSURANCE ISSUE 2 0.0001
210 SHOCK 3 0.0001
211 PROCEDURAL COMPLICATION 1 0.0001
212 ANKLE FRACTURE 2 0.0001
213 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
214 PELVIC FRACTURE 1 0.0001
215 PNEUMOTHORAX 2 0.0001
216 NEUTROPHIL COUNT DECREASED 5 0.0001
217 POLYURIA 1 0.0001
218 LIVE BIRTH 1 0.0001
219 CIRCULATORY COLLAPSE 2 0.0001
220 ANURIA 1 0.0001
221 MUSCLE STRAIN 1 0.0001
222 HYSTERECTOMY 1 0.0001
223 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
224 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
225 WRONG DRUG ADMINISTERED 1 0.0001
226 PULMONARY OEDEMA 5 0.0001
227 ANAL INCONTINENCE 1 0.0001
228 LACERATION 1 0.0001
229 SINUS BRADYCARDIA 1 0.0001
230 LIVER FUNCTION TEST ABNORMAL 3 0.0001
231 INFLAMMATORY BOWEL DISEASE 1 0.0001
232 INABILITY TO AFFORD MEDICATION 1 0.0001
233 BRAIN INJURY 1 0.0001
234 DRUG LEVEL DECREASED 1 0.0001
235 BODY TEMPERATURE INCREASED 2 0.0001
236 MOUTH ULCERATION 2 0.0001
237 HEAD INJURY 3 0.0001
238 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
239 STAPHYLOCOCCAL INFECTION 3 0.0001
240 MELAENA 2 0.0001
241 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
242 VENTRICULAR FIBRILLATION 1 0.0001
243 BLOOD CALCIUM DECREASED 1 0.0001
244 INTERNAL HAEMORRHAGE 1 0.0001
245 HYPOKALAEMIA 4 0.0001
246 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
247 EYELID OEDEMA 1 0.0001
248 HYPERKALAEMIA 3 0.0001
249 DISEASE RECURRENCE 4 0.0001
250 ADRENAL INSUFFICIENCY 1 0.0001
251 INJECTION SITE EXTRAVASATION 1 0.0001
252 PHARYNGITIS 1 0.0001
253 HEPATIC FUNCTION ABNORMAL 3 0.0001
254 LEUKOPENIA 4 0.0001
255 BRAIN OEDEMA 1 0.0001
256 INJECTION SITE IRRITATION 1 0.0001
257 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
258 HAEMATOMA 2 0.0001
259 DEEP VEIN THROMBOSIS 5 0.0001
260 PLATELET COUNT INCREASED 1 0.0001
261 SARS-COV-2 TEST POSITIVE 1 0.0001
262 EYE HAEMORRHAGE 1 0.0001
263 ABORTION SPONTANEOUS 3 0.0001
264 FREQUENT BOWEL MOVEMENTS 2 0.0001
265 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
266 ACUTE HEPATIC FAILURE 1 0.0001
267 PROCEDURAL PAIN 2 0.0001
268 HYPOMAGNESAEMIA 1 0.0001
269 HEPATOCELLULAR INJURY 1 0.0001
270 BRONCHOSPASM 1 0.0001
271 SEPTIC SHOCK 3 0.0001
272 TACHYCARDIA 6 0.0001
273 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
274 DEVICE RELATED INFECTION 1 0.0001
275 ACUTE MYELOID LEUKAEMIA 1 0.0001
276 ARRHYTHMIA 3 0.0001
277 PULMONARY EMBOLISM 6 0.0001
278 PREMATURE DELIVERY 1 0.0001
279 LACTIC ACIDOSIS 2 0.0001
280 HEART RATE INCREASED 6 0.0001
281 VENTRICULAR TACHYCARDIA 1 0.0001
282 CYTOMEGALOVIRUS INFECTION 1 0.0001
283 FACE OEDEMA 1 0.0001
284 CANDIDA INFECTION 1 0.0001
285 NEUROTOXICITY 1 0.0001
286 HYPOXIA 2 0.0001
287 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
288 PLATELET COUNT DECREASED 6 0.0001
289 ISCHAEMIC STROKE 1 0.0001
290 CEREBRAL HAEMORRHAGE 2 0.0001
291 MYELOSUPPRESSION 2 0.0001
292 LEUKOCYTOSIS 1 0.0001
293 RESPIRATORY FAILURE 4 0.0001
294 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
295 BACTERIAL INFECTION 1 0.0001
296 BLOOD SODIUM DECREASED 1 0.0001
297 HAEMORRHOIDS 1 0.0001
298 ORAL HERPES 1 0.0001
299 HYPOTENSION 10 0.0000
300 THROMBOSIS 4 0.0000
301 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
302 RHABDOMYOLYSIS 2 0.0000
303 CARDIO-RESPIRATORY ARREST 2 0.0000
304 HAEMORRHAGE 5 0.0000
305 RENAL FAILURE ACUTE 2 0.0000
306 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
307 BLOOD PRESSURE INCREASED 7 0.0000
308 BLOOD PRESSURE DECREASED 3 0.0000
309 HEPATOTOXICITY 1 0.0000
310 THROAT IRRITATION 2 0.0000
311 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
312 PERICARDIAL EFFUSION 1 0.0000
313 ANAEMIA 8 0.0000
314 MENTAL IMPAIRMENT 1 0.0000
315 AGITATION 3 0.0000
316 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
317 CARDIOVASCULAR DISORDER 1 0.0000
318 MUSCULOSKELETAL PAIN 2 0.0000
319 OFF LABEL USE 33 0.0000
320 JAUNDICE 1 0.0000
321 OEDEMA 2 0.0000
322 LIMB INJURY 1 0.0000
323 CARDIAC ARREST 3 0.0000
324 RESPIRATORY ARREST 1 0.0000
325 HAEMATOCHEZIA 2 0.0000
326 ANAPHYLACTIC REACTION 2 0.0000
327 DIVERTICULITIS 1 0.0000
328 SEPSIS 4 0.0000
329 HAEMOPTYSIS 1 0.0000
330 WOUND 1 0.0000
331 OXYGEN SATURATION DECREASED 2 0.0000
332 CEREBROVASCULAR ACCIDENT 6 0.0000
333 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
334 PYREXIA 12 0.0000
335 NEEDLE ISSUE 1 0.0000
336 INTENTIONAL PRODUCT MISUSE 3 0.0000
337 SURGERY 2 0.0000
338 BLOOD POTASSIUM DECREASED 1 0.0000
339 HEPATIC FAILURE 1 0.0000
340 HYPERTENSION 7 0.0000
341 EPILEPSY 1 0.0000
342 DRUG ADMINISTRATION ERROR 1 0.0000
343 SWOLLEN TONGUE 1 0.0000
344 DRUG-INDUCED LIVER INJURY 1 0.0000
345 CYSTITIS 1 0.0000
346 PNEUMONIA 10 0.0000
347 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
348 NEUTROPENIA 4 0.0000
349 HAEMATURIA 1 0.0000
350 DELIRIUM 1 0.0000
351 BURNING SENSATION 2 0.0000
352 C-REACTIVE PROTEIN INCREASED 1 0.0000
353 HYPERGLYCAEMIA 1 0.0000
354 ACCIDENTAL OVERDOSE 1 0.0000
355 INTESTINAL OBSTRUCTION 1 0.0000
356 ACUTE KIDNEY INJURY 4 0.0000
357 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
358 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
359 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
360 EXTRA DOSE ADMINISTERED 1 0.0000
361 RENAL IMPAIRMENT 2 0.0000
362 COLITIS ULCERATIVE 1 0.0000
363 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
364 SKIN DISCOLOURATION 1 0.0000
365 CHEST PAIN 4 0.0000
366 PRODUCTIVE COUGH 1 0.0000
367 BLOOD GLUCOSE DECREASED 1 0.0000
368 INFECTION 3 0.0000
369 HYPOGLYCAEMIA 1 0.0000
370 ATRIAL FIBRILLATION 2 0.0000
371 AGGRESSION 1 0.0000
372 FLUSHING 2 0.0000
373 HAEMOGLOBIN DECREASED 2 0.0000
374 BRADYCARDIA 1 0.0000
375 TREATMENT NONCOMPLIANCE 1 0.0000
376 MEDICATION ERROR 1 0.0000
377 URTICARIA 3 0.0000
378 PANCYTOPENIA 1 0.0000
379 COUGH 5 0.0000
380 HYPONATRAEMIA 1 0.0000
381 URINARY TRACT INFECTION 3 0.0000
382 SEIZURE 2 0.0000
383 ABDOMINAL PAIN 4 0.0000
384 CHILLS 2 0.0000
385 DISEASE PROGRESSION 2 0.0000
386 CATARACT 1 0.0000
387 EXPOSURE DURING PREGNANCY 1 0.0000
388 AMNESIA 1 0.0000
389 BLOOD CREATININE INCREASED 1 0.0000
390 INFUSION RELATED REACTION 1 0.0000
391 FEBRILE NEUTROPENIA 1 0.0000
392 INJECTION SITE PRURITUS 1 0.0000
393 DYSPNOEA 8 0.0000
394 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
395 PAIN IN EXTREMITY 4 0.0000
396 CHRONIC KIDNEY DISEASE 1 0.0000
397 INCORRECT DOSE ADMINISTERED 3 0.0000
398 DIABETES MELLITUS 1 0.0000
399 PERIPHERAL SWELLING 2 0.0000
400 DRUG INEFFECTIVE 16 0.0000
401 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
402 DEVICE ISSUE 1 0.0000
403 PRODUCT USE ISSUE 2 0.0000
404 ANXIETY 3 0.0000
405 NEUROPATHY PERIPHERAL 1 0.0000
406 DYSPEPSIA 1 0.0000
407 SYNCOPE 1 0.0000
408 CHEST DISCOMFORT 1 0.0000
409 OVERDOSE 2 0.0000
410 CONSTIPATION 2 0.0000
411 THROMBOCYTOPENIA 1 0.0000
412 FEELING ABNORMAL 2 0.0000
413 OEDEMA PERIPHERAL 1 0.0000
414 INJECTION SITE ERYTHEMA 1 0.0000
415 LOSS OF CONSCIOUSNESS 1 0.0000
416 HYPERHIDROSIS 1 0.0000
417 RENAL FAILURE 1 0.0000
418 HYPOAESTHESIA 1 0.0000
419 HOSPITALISATION 1 0.0000
420 VOMITING 3 0.0000
421 CONFUSIONAL STATE 1 0.0000
422 TREMOR 1 0.0000
423 FALL 2 0.0000
424 DEATH 5 0.0000
425 MYOCARDIAL INFARCTION 1 0.0000
426 COVID-19 1 0.0000
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
428 HYPERSENSITIVITY 1 0.0000
429 GAIT DISTURBANCE 1 0.0000
430 PRURITUS 2 0.0000
431 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
432 ERYTHEMA 1 0.0000
433 ABDOMINAL PAIN UPPER 1 0.0000
434 DIARRHOEA 3 0.0000
435 MALAISE 2 0.0000
436 WEIGHT INCREASED 1 0.0000
437 BACK PAIN 1 0.0000
438 DIZZINESS 2 0.0000
439 INSOMNIA 1 0.0000
440 PRODUCT DOSE OMISSION ISSUE 1 0.0000
441 CONDITION AGGRAVATED 1 0.0000
442 PAIN 2 0.0000
443 ASTHENIA 1 0.0000
444 RASH 1 0.0000
445 HEADACHE 1 0.0000
446 FATIGUE 1 0.0000